grifols biomat compensation - Poursteady Utilities

MADRID, April 14 (Reuters) - Spanish drug maker Grifols (GRLS.MC), opens new tab, battling a plunge in its share price this year, plans to add independent directors to its audit and compensation ...

Jan 9 (Reuters) - Spanish drugmaker Grifols, whose shares slumped on Tuesday after hedge fund Gotham City Research questioned its accounts, has grown from a family-run blood testing lab founded in ...

Reuters: Spanish drug maker Grifols will bring in independent directors, chairman tells newspaper

Spanish drug maker Grifols will bring in independent directors, chairman tells newspaper

FiercePharma: Grifols files lawsuit against hedge fund for making 'false and misleading statements'

Read Also: Elevate Your Morning Routine at Our Intimate Pourover Cafe

Spanish plasma medicines producer Grifols is clapping back at Gotham City Research, filing a lawsuit that accuses the New York hedge fund of “knowingly making false and misleading statements” about ...

Grifols files lawsuit against hedge fund for making 'false and misleading statements'

Yahoo Finance: Assessing Grifols (BME:GRF) Valuation After Recent Share Price Weakness And Perceived Discount

Assessing Grifols (BME:GRF) Valuation After Recent Share Price Weakness And Perceived Discount

Read Also: Bidmc Portal Patient

Grifols is a promising buy opportunity thanks to its potential to reduce its net debt/EBITDA ratio. The company's focus on deleveraging is showing results and is supported by higher savings and better ...

Read Also: Blonde Messy Bob Hairstyles

Spanish plasma-derived medicines company Grifols announced that it has successfully completed the refinancing of its 2027 debt maturities through a new credit agreement structured as a Term Loan B ...

LONDON, Jan 9 (Reuters Breakingviews) - Short seller Gotham City Research is aiming at an already battered target. On Tuesday, the hedge fund knocked up to 42% off Grifols’ (GRLS.MC), opens new tab ...